Immunometabolic Contributions of Atopobiaceae Family Members in Human Papillomavirus Infection, Cervical Dysplasia, and Cancer - Summary - MDSpire

Immunometabolic Contributions of Atopobiaceae Family Members in Human Papillomavirus Infection, Cervical Dysplasia, and Cancer

  • By

  • Nicole R Jimenez

  • Vianney Mancilla

  • Paweł Łaniewski

  • Melissa M Herbst-Kralovetz

  • November 1, 2024

  • 0 min

Share

Objective:

To investigate the role of Atopobiaceae in the cervicovaginal microenvironment and its impact on HPV persistence and cervical cancer progression, focusing on specific immunometabolic factors.

Key Findings:
  • Higher prevalence of Atopobiaceae in Hispanic women with increased gravidity and parity, indicating a potential demographic risk factor.
  • F. vaginae and F. species type 2 associated with high-risk HPV genotypes 31 and 52, suggesting a direct link to HPV persistence.
  • Atopobiaceae negatively correlated with Lactobacillus and positively correlated with Sneathia, Dialister, Anaerococcus, Prevotella, and Bifidobacterium/Gardnerella, highlighting the microbiome's complexity.
  • Proinflammatory cytokines and immune checkpoint proteins positively associated with Atopobiaceae-rich profiles, indicating a potential mechanism for immune evasion.
  • Elevated prooncogenic metabolites found in women colonized by Atopobiaceae, suggesting metabolic dysregulation.
Interpretation:

Atopobiaceae may contribute to HPV persistence and cervical cancer development through modulation of inflammation, immune evasion, and metabolic dysregulation, warranting further investigation into these mechanisms.

Limitations:
  • Study population primarily consisted of Hispanic and non-Hispanic White women, limiting generalizability and introducing potential demographic biases.
  • Cross-sectional design does not establish causation, necessitating longitudinal studies.
Conclusion:

Atopobiaceae represents a significant factor in the cervicovaginal microbiome that may influence HPV persistence and cervical cancer risk, suggesting potential for targeted interventions such as microbiome modulation or therapeutic strategies.

Original Source(s)

Related Content